(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Venice’s newest marvel is a wild, acrobatic dolphin. His refusal to leave puts him in danger - 27 Popular Vacation destinations In China
- 3A definitive Bike Standoff: Decision in favor of Your Number one Ride
- 4Miley Cyrus details her fear of paper, says fiancé Maxx Morando opens their packages outside: 'That's really why I got engaged'
- 5Figure out How to Involve a Brain science Certification in Showcasing
- The Best 15 Applications for Efficiency and Association
- Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
- Five held on suspicion of planning attack on German Christmas market
- Brazil's ex-president Bolsonaro operated on for hernia
- Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group
- Congress is running out of time to extend ACA subsidies as the GOP moves on to an alternative plan. Here's where things stand.
